Screener
Celldex Therapeutics CLDX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's total assets?
- Celldex Therapeutics (CLDX) reported total assets of $782.35M in Q2 2026.
- How has Celldex Therapeutics's total assets changed year-over-year?
- Celldex Therapeutics's total assets increased by 13.0% year-over-year, from $692.41M to $782.35M.
- What is the long-term trend for Celldex Therapeutics's total assets?
- Over 5 years (2020 to 2025), Celldex Therapeutics's total assets has grown at a 19.8% compound annual growth rate (CAGR), from $235.84M to $582.98M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Celldex Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude